Loading clinical trials...
Loading clinical trials...
This project will develop a multi-component, technology-delivered intervention designed to reduce HIV and intersectional stigma and improve the use of HIV pre-exposure prophylaxis (PrEP) among HIV-neg...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Massachusetts, Worcester
Collaborators
NCT07071623 · Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis
NCT07221747 · Oral Pre-exposure Prophylaxis (PrEP), Long-acting Injectable Cabotegravir for PrEP
NCT06056544 · HIV Prevention, HIV Pre-exposure Prophylaxis
NCT06158126 · Pre-exposure Prophylaxis, HIV Prevention, and more
NCT05856942 · HIV Prevention, Pre-exposure Prophylaxis, and more
Institute of HIV Research and Innovation
Bangkok
Rainbow Sky Association of Thailand
Bangkok
SWING Foundation
Bangkok
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions